Affiliate disclosure: As an Amazon Associate, this site earns from qualifying purchases linked in this article.
Navigating the changes of perimenopause often brings questions about shifts in well-being, including sexual health. Many women experience changes in libido during this time, leading them to explore various options.
Dehydroepiandrosterone (DHEA) is a hormone produced naturally by the body, which can be converted into other hormones, including androgens and estrogens [1]. As a DHEA information site, we aim to provide an evidence-based overview of DHEA’s potential role for low libido in perimenopausal women, reviewing current research findings.
Understanding Libido Changes in Perimenopause
Perimenopause is a transitional phase leading up to menopause, marked by fluctuating hormone levels. Many women report a decrease in sexual desire or satisfaction during this time, which can be influenced by a complex interplay of hormonal changes, psychological factors, and life circumstances. While hormonal shifts are often considered, it’s important to recognize that libido is multifaceted.
What is DHEA and How Might it Relate to Libido?
DHEA is a steroid hormone that serves as a precursor to both estrogens and androgens [1]. Levels of DHEA tend to decline with age [2]. Because DHEA can be converted into androgens, which are known to play a role in female sexual function, there has been interest in its potential for supporting libido [3][4][5].
The theory is that by supplementing DHEA, the body might have more substrate to produce these other hormones, potentially influencing sexual desire and arousal. However, the exact mechanisms and individual responses can vary.
Evidence for Oral DHEA and Low Libido in Women
Research exploring oral DHEA for low libido in women has yielded mixed results, and the evidence strength for this specific topic is considered moderate. Some studies have investigated the impact of oral DHEA on sexual function in postmenopausal women with low libido.
One randomized trial in postmenopausal women with low libido found that oral DHEA treatment was associated with improvements in sexual function, well-being, and menopausal symptoms [6]. Another systematic review and meta-analysis focusing on postmenopausal women with normal adrenal function indicated potential benefits of systemic DHEA in some areas, though the overall picture for libido specifically can be complex [7].
It’s important to note that many studies in this area have involved postmenopausal women, and direct evidence specifically for perimenopausal women with low libido is less extensive. Research also needs to carefully consider the dosage, duration, and individual health profiles when evaluating outcomes.
Evidence for Vaginal DHEA and Low Libido
Beyond oral DHEA, localized vaginal DHEA has been studied, primarily for symptoms related to genitourinary syndrome of menopause (GSM), which can also impact sexual function. A systematic review from 2024 noted that hormonal treatments, including vaginal DHEA, are options for genitourinary syndrome of menopause [8].
Another systematic review and meta-analysis from 2018 evaluated vaginal therapies for sexual function and orgasm in menopausal women, finding some efficacy for vaginal DHEA [9]. While these studies indicate potential benefits for vaginal health and related aspects of sexual function, their direct applicability to core libido (desire) in perimenopausal women requires careful interpretation. Vaginal DHEA primarily works locally to address vaginal dryness and discomfort, which can certainly impact the experience of sex, but may not directly influence desire in the same way as systemic DHEA.
DHEA in Specific Populations: Sheehan Syndrome
While not directly focused on perimenopause, a randomized, double-blind, placebo-controlled crossover trial investigated DHEA’s effect on sexual function in women with Sheehan Syndrome, a condition involving pituitary insufficiency. This study found that DHEA administration led to improvements in certain aspects of sexual function in this specific population [10]. While interesting, findings from specific medical conditions like Sheehan Syndrome may not be directly transferable to the general perimenopausal population experiencing age-related hormonal fluctuations.
References
- Dehydroepiandrosterone replacement therapy. Seminars in reproductive medicine, 2004
- Clinical review: DHEA replacement for postmenopausal women. The Journal of clinical endocrinology and metabolism, 2011
- Androgens in women. The Journal of steroid biochemistry and molecular biology, 2003
- Androgen therapy in women. European journal of endocrinology, 2006
- Androgen Therapy in Women. Journal of women’s health (2002), 2020
- A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido. The journal of sexual medicine, 2009
- Clinical review: The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. The Journal of clinical endocrinology and metabolism, 2014
- Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause : A Systematic Review. Annals of internal medicine, 2024
- Efficacy of vaginal therapies alternative to vaginal estrogens on sexual function and orgasm of menopausal women: A systematic review and meta-analysis of randomized controlled trials. European journal of obstetrics, gynecology, and reproductive biology, 2018
- DHEA on Sexual Function in Sheehan Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial. The Journal of clinical endocrinology and metabolism, 2022
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
